EP3845557
METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.6.2016EP published:
2.8.2023EP application number:
20208043.8
EPO information:
European Patent Register
Max expiry date:
11.6.2036
Title in English:
METHOD TO TREAT CANCER WITH ENGINEERED T-CELLSLanguage of the patent:
English
Timeline
Today
12.6.2016EP application
2.8.2023EP Publication
Owner
Name:
Lentigen Technology, Inc.Address:
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878, US
Inventor
Name:
DROPULIC, BoroAddress:
Ellicott City, MD 21042, US
Name:
ORENTAS, RimasAddress:
Washington, MD 20008, US
Name:
SCHNEIDER, DinaAddress:
Potomac, MD 20854, US
Name:
KRUEGER, WinfriedAddress:
Kensington, MD 20895, US
Priority
Number:
201562175003 PDate:
12.6.2015Country:
US
Classification
Categories:
A61K 35/17, A61K 38/17, A61K 39/00, A61P 7/00, A61P 35/00, A61P 35/02, C12N 5/0783, C07K 14/725